Michael D. Dake
39Patents
18h-index
22Co-inventors
81Inventor score
Filing activity: Jan 9, 1989 → Mar 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6302906A | System for delivering a prosthesis | Emerging Cross-Sectional Technologies | 1,054 | Expired |
| US5693083A | Thoracic graft and delivery catheter | Human Necessities | 472 | Expired |
| US6051020A | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 407 | Expired |
| US5527354A | Stent formed of half-round wire | Human Necessities | 385 | Expired |
| US5916263A | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 355 | Expired |
| US5716365A | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 312 | Expired |
| US5199939A | Radioactive catheter | Human Necessities | 293 | Expired |
| US6117167A | Endoluminal prosthesis and system for joining | Emerging Cross-Sectional Technologies | 256 | Expired |
| US6346118B1 | Thoracic graft and delivery catheter | Human Necessities | 242 | Expired |
| US4968307A | Catheter for uniform distribution of therapeutic fluids | Human Necessities | 145 | Expired |
| US4927418A | Catheter for uniform distribution of therapeutic fluids | Human Necessities | 134 | Expired |
| US7056339B2 | Drug delivery platform | Performing Operations; Transporting | 56 | Expired |
| US7048939B2 | Methods for the inhibition of neointima formation | Human Necessities | 52 | Expired |
| US7780720B2 | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 29 | Expired |
| US8404249B2 | Compositions and methods for topical application and transdermal delivery of botulinum toxins | Emerging Cross-Sectional Technologies | 23 | Active |
| US7901449B2 | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 22 | Active |
| US7807780B2 | Multi-component biological transport systems | Performing Operations; Transporting | 20 | Expired |
| US8398997B2 | Compositions and methods for topical application and transdermal delivery of botulinum toxins | Emerging Cross-Sectional Technologies | 18 | Active |
| US9180081B2 | Compositions and methods for topical application and transdermal delivery of botulinum toxins | Chemistry; Metallurgy | 15 | Active |
| US7942919B2 | Bifurcated endoluminal prosthesis | Emerging Cross-Sectional Technologies | 14 | Active |
| US8092788B2 | Compositions and methods for topical diagnostic and therapeutic transport | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8022179B2 | Compositions and methods for topical application and transdermal delivery of an oligopeptide | Chemistry; Metallurgy | 12 | Active |
| US9211248B2 | Compositions and methods for topical application and transdermal delivery of botulinum toxins | Chemistry; Metallurgy | 12 | Active |
| US10080786B2 | Methods for treating pain by topical application and transdermal delivery of botulinum toxin | Chemistry; Metallurgy | 10 | Active |
| US9314328B2 | Branched stent graft device and deployment | Mechanical Engineering; Lighting; Heating | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.